TrialJournal of cachexia, sarcopenia and muscle2025

Early Administration of Bosentan in High-Risk COVID-19 Outpatients at Risk of Sarcopenia: A Randomized, Double-Blind, Placebo-Controlled Trial.

Shaahin Shahbazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.